Regulating and assessing risks of cholinesterase-inhibiting pesticides: Divergent approaches and interpretations

Journal of Toxicology and Environmental Health - Part B: Critical Reviews

Volumn 2, Issue 2, 1999, Pages 105-160

  Carlock, Linda L ^a,b   Chen, W L ^c   Gordon, Elliot B ^d   Killeen, James C ^e,f   Manley, Ann ^g   Meyer, Linda S ^h   Mullin, Linda S ⁱ   Pendino, Kim J ^j   Percy, Adrian ^k   Sargent, Dana E ^l   Seaman, Luann R ^m   Svanborg, Nina Karin ⁿ   Stanton, Richard H ^o   Tellone, Carmella I ^o   Goethem, Dan L Van ^p  

^a West Lakewood   (United States)

^b Wilbur Ellis Company   (United States)

^c DOW AGROSCIENCES LLC   (United States)

^d Makhteshim Agan of North America Inc   (United States)

^e Ricerca Inc   (United States)

^f ISK Biosciences Corporation   (United States)

^g Amvac Chemical Corporation   (United States)

^h Syngenta Crop Protection Inc   (United States)

ⁱ DUPONT COMPANY   (United States)

^j PFIZER INC   (United States)

^k Rhone Poulenc Ag Company   (United States)

^l Zeneca Agricultural Products   (United States)

^m FMC CORPORATION   (United States)

ⁿ Cheminova AS   (Denmark)

^o Valent BioSciences Corporation   (United States)

^p BAYER CORPORATION   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ACETYLCHOLINESTERASE; CARBAMATE PESTICIDE; CHOLINE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; DEMETON; DICHLORVOS; DIMEFOX; DIMPYLATE; DONEPEZIL; DYFLOS; METRIFONATE; MEVINPHOS; MONOCLONAL ANTIBODY; ORGANOPHOSPHATE PESTICIDE; PARAOXON; PARATHION; PROPAPHOS; SARIN; TACRINE; UNCLASSIFIED DRUG;

CHOLINERGIC ACTIVITY; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; DOG; DRUG INHIBITION; ENZYME INHIBITION; FEMALE; HUMAN; LUNG EDEMA; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; RABBIT; RAT; REGULATORY MECHANISM; RESPIRATORY FAILURE; REVIEW; RISK ASSESSMENT; SAFETY; SENSORY DYSFUNCTION; WORKER;

ACETYLCHOLINESTERASE; ANIMALS; BRAIN; CARBAMATES; CHOLINESTERASE INHIBITORS; CHOLINESTERASES; DIET; ERYTHROCYTES; FOOD CONTAMINATION; HUMANS; INSECTICIDES; OCCUPATIONAL HEALTH; ORGANOPHOSPHORUS COMPOUNDS; PUBLIC POLICY; REFERENCE VALUES; RISK ASSESSMENT;

EID: 0033369583     PISSN: 10937404     EISSN: 15216950     Source Type: Journal    
DOI: 10.1080/109374099281197     Document Type: Article

References (69)

1. Aldridge, W. N. 1996. Mechanisms and concepts in toxicology. London: Taylor & Francis.
2. Ames, R. G., Steenland, K., Jenkins, B., Chrislip, D., and Russo, J. 1995. Chronic neurologic sequelae to cholinesterase inhibition among agricultural pesticide applicators. Arch. Environ. Health 50:440-444.
3. Bushnell, P. J., Pope, C. N., and Padilla, S. 1993. Behavioral and neurochemical effects of acute chlorpyrifos in rats: Tolerance to prolonged inhibition of cholinesterase. J. Pharmacol. Exp. Ther. 266:1007-1017.
4. California Environmental Protection Agency. 1994. Residues in Fresh Produce-1992. California Department of Pesticide Regulation, Pesticide Enforcement Branch, Sacramento, CA.
5. Castellano, C., Petkov, V., Kehaev, R., and Panusheva, N. 1989. Age-determined changes in the effects of a newly synthesized cholinesterase inhibitor on exploratory behavior, memory and striatal cholinesterase activity in rats. Acta Physiol. Pharmacol. Bulg. 15:3-9.
6. Cochran, R. C., Kishiyama, J., Aldouj, C., Carr, W. C., Jr., and Pfeifer, K. F. 1995. Chlorpyrifos: Hazard assessment based on a review of the effects of short-term and long-term exposure in animals and humans. Food Chem. Toxicol. 33:65-172.
7. Crismon, M. L. 1998. Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease. Pharmacotherapy 18:47-54.
8. Drachman, D. A., and Leavitt, J. 1974. Human memory and the cholinergic system. Relation to aging. Arch. Neurol. 30:113-121.
9. Ecobichon, D. J., and Comeau, A. M. 1973. Pseudocholinesterases of mammalian plasma: Physicochemical properties and organophosphate inhibition in eleven species. Toxicol. Appl. Pharmacol. 24:92-100.
10. Edson, E. F. 1964. Summaries of toxicological data: No-effect levels of three organophosphates in the rat, pig and man. Food Cosmet. Toxicol. 2:311-316.
11. Ellenhorn, M. J., and Barceloux, D. G. 1988. Medical toxicology: The diagnosis and treatment of human poisoning, pp. 1077-1078. New York, NY: Elsevier.
12. Endo, G., Horiguchi, S., Kiyota, I., and Kurosawa, K. 1987. Serum cholinesterase and erythrocyte acetylcholinesterase activities in workers occupationally exposed to organophosphates. Proc. Asia-Pacific Symp. Environ. Occup. Toxicol., pp. 561-564.
13. Engel, L. S., Keifer, M. C., Checkoway, H., Robinson, L. R., and Vaughan, T. L. 1998. Neurophysiological function in farm workers exposed to organophosphate pesticides. Arch. Environ. Health 53:7-14.
14. Fed. Reg. 1996. Request for Proposals for Enforceable Consent Agreement; Dermal Absorption Rate Testing of Eighty OSHA Chemicals; Solicitation of Interested Parties. Text of Test Protocol. 61: 14733.
15. Fiedler, N., Kipen, H., Kelly-McNeil, K., and Fenske, R. 1997. Long-term use of organophosphates and neuropsychological performance. Am. J. Ind. Med. 32:487-496.
16. Food and Drug Administration. 1994. Pesticide Program Residue Monitoring-1994. www.fda.gov
17. Gallo, M. A., and Lawryk, N. J. 1991. Organic phosphorus pesticides. In Handbook of Pesticide Toxicology, Vol. 2, Classes of Pesticides, ed. W. Hayes, pp. 917-1123. San Diego, CA: Academic Press.
18. Gelgardi, R. C., and Mountford, M. K. 1993. Infant formulas: Evidence of the absence of pesticide residues. Regul. Toxicol. Pharmacol. 17:181-192.
19. Grob, D., and Harvey, J. C. 1958. Effects in man of the anticholinesterase compound sarin (isopropyl methyl phosphonofluoridate). J. Clin. Invest. 37:350-368.
20. Grob, D., Lilienthal, J. L., Jr., Harvey, A. M., and Jones, B. F. 1947. The administration of di-isopropyl fluorophosphate (DFP) to man. Bull. Johns Hopkins Hosp. 81:217-244.
21. Hayes, G. R., Funckes, A. J., and Hartwell, W. V. 1964. Dermal exposure of human volunteers to parathion. Arch. Environ. Health 8:829-833.
22. Hayes, W. 1982. Pesticides studied in man. Baltimore, MD: Williams & Wilkins.
23. Heath, A. J. W., and Vale, J. A. 1992. Clinical presentation and diagnosis of acute organophosphorus insecticide and carbamate poisoning. In Clinical and experimental toxicology of organophosphates and carbamates, eds. B. Ballantyne and T. C. Marrs, pp. 513-519. Oxford, England: Butterworth-Heinemann.
24. International Life Sciences Institute. 1995. Assessing Exposure to Multiple Organophosphate Pesticides in Foods. Document prepared by TAS, Inc., Washington, DC.
25. Jann, M. W. 1998. Preclinical pharmacology of metrifonate. Pharmacotherapy 18:55-67.
26. Joint Meeting on Pesticide Residues. 1988. Excerpt of the transcript from the 1988 Joint Meeting on Pesticide Residues. Pesticide Residues in Food-1988. FAO Plant Production and Protection Paper 92. Food and Agricultural Organization of the United Nations, Rome, Italy.
27. Joint Meeting on Pesticide Residues. 1995. Pesticide Residues in Food-1995: FAO Plant Production and Protection Paper 133, p. 4. Food and Agricultural Organization of the United Nations, Geneva, Switzerland. www.fao.org
28. Ketchum, J. S., Sidell, F. R., and Crowell, E. G., 1973. Atropine, scopolamine and ditran: Comparative pharmacology and antagonists in man. Psychopharmacologia 28:121-145.
29. Knaak, J. B., Al-Bayanti, M. A., and Raabe, O. G. 1993. Physiologically based pharmacokinetic modeling to predict dose and cholinesterase inhibition i n workers exposed to organophosphates and carbamate pesticides. In Health risk assessment: Dermal and inhalation exposure and absorption of toxicants, pp. 3-29. Boca Raton, FL: CRC Press.
30. Lotti, M. 1995. Cholinesterase inhibition: Complexities in interpretation. Clin. Chem. 41:1814-1818.
31. Ludomirsky, A., Klein, H. O., and Sarelli, P. 1982. Q-T prolongation and polymorphous (torsades de pointes) ventricular arrhythmias associated with organophosphate poisoning. Am. J. Cardiol. 49: 1654-1658.
32. Maurissen, J., Shankar, M., and Mattsson, J. 1996. Chlorpyrifos: Cognitive Study in Adult Long-Evans Rats: Lab project number K-044793-096. Unpublished study prepared by the Toxicology Research Laboratory, Dow Chemical Co. EPA MRID No. 44020901.
33. Maynard, R. L., and Beswick, F. W. 1992. Organophosphorous compounds as chemical warfare agents. In Clinical and experimental toxicology of organophosphates and carbamates, eds. B. Ballantyne and T. C. Marrs, pp. 373-385. Oxford, England: Butterworth-Heinemann.
34. Michalek, H., Fortuna, S., Volpe, M. T., and Pintor, A. 1990. Age-related differences in the recovery rate of brain cholinesterases, choline acetyltransferase and muscarinic acetylcholine receptor sites after a subacute intoxication of rats with the anticholinesterase agent, isofluorophate. Acta Neurobiol. Exp. 50:23 7-249.
35. Mohammed, A. H. 1993. Effects of cholinesterase inhibitors on learning and memory in rats: A brief review with special reference to THA. Acta Neurol. Scand. Suppl. 149:13-15.
36. Moretto, A., and Lotti, M. 1998. Poisoning by organophosphorus insecticides and sensory neuropathy. J. Neurol. Neurosurg. Psychiatry 64:463-468.
37. Namba, T., Nolte, C. T., and Jackrel, J. 1971. Poisoning due to organophosphate insecticides. Acute and chronic manifestations. Am. J. Med. 50:475-492.
38. Nolan, R. J., Rick, D. L., Freshour, N. L., and Saunders, J. H. 1984. Chlorpyrifos pharmacokinetics in human volunteers. Toxicol. Appl. Pharmacol. 73:8-15.
39. Nostrandt, A. C., Padilla, S., and Moser, V. C. 1997. The relationship of oral chlorpyrifos effects on behavior, cholinesterase inhibition and muscarinic receptor density in rat. Pharmacol. Biochem. Behav. 58:15-23.
40. O'Brien, R. D. 1967. Insecticides: Action and metabolism. New York: Academic Press.
41. Organization for Economic Cooperation and Development. 1994. Proposed Guidelines: Percutaneous Absorption: In Vitro Method; Percutaneous Absorption: In Vivo Method. TGP/94.68&69. www.oecd.org
42. Padilla, S., Moser, V. C., Pope, C. N., and W. S. Brimijoin. 1992. Paraoxon toxicity is not potentiated by prior reduction in blood acetylcholinesterase. Toxicol. Appl. Pharmacol. 117:110-115.
43. Padilla, S., Wilson, V. Z., and P. J. Bushnell. 1994. Studies on the correlation between blood cholinesterase inhibition and "target tissue" inhibition in pesticide-treated rats. Toxicology 92:1125.
44. Ray, D. 1998. Organophosphorus Esters: An Evaluation of Chronic Neurotoxic Effects. Leicester, UK: Institute for Environment and Health, University of Leicester.
45. Rider, J. A., Moeller, H. C., Puletti, E. J., and Swader, J. I. 1969. Toxicity of parathion, systox, octamethyl pyrophosphoramide, and methyl parathion in man. Toxicol. Appl. Pharmacol. 14:603-611.
46. Rider, J. A., Puletti, E. J., and Swader, J. I. 1975. The minimal oral toxicity level for mevinphos in man. Toxicol. Appl. Pharmacol. 32:97-100.
47. Roy, R. R., Albert, R. H., Wilson, P., Laski, R. R., Roberts, J. I., Hoffman, T. J., Bong, R. L., Bohannon, B. O., and Yess, N. J. 1995. U.S. Food and Drug Administration Pesticide Program: Incidence Level Monitoring of Domestic and Imported Roses and Tomatoes. J. AOAC Int. 78(4).
48. Scarsella, G., Toschi, G., Bareggi, S. R., and Giacobini, E. 1979. Molecular forms of cholinesterases in cerebrospinal fluid, blood plasma, and brain tissue of the beagle dog. J. Neurosci. Res. 4:19-24.
49. Sette, W. F. 1997. Office of Pesticide Programs Science Policy on the Use of Data on Cholinesterase Inhibition for Risk Assessments of Organophosphate and Carbamate Pesticides. Report prepared for the Office of Pesticide Programs, U.S. Environmental Protection Agency, 30 August. Washington, DC.
50. Sheets, L. P., Hamilton, B. F., Sanga, G. K., and Thyssen, J. H. 1997. Subchronic neurotoxicity screening studies with six organophosphate insecticides: An assessment of behavior and morphology relative to cholinesterase inhibition. Fundam. Appl. Toxicol. 35:101-119.
51. Siegfreid, K. R. 1993. Pharmacodynamic and early clinical studies with Velnarcine. Acta Neurol. Scand. Suppl. 149:2 6-28.
52. Stephens, R., and Barker, P. 1998. Role of human neurobehavioural tests in regulatory activity on chemicals. Occup. Environ. Med. 55:210-214.
53. Stephens, R., Spurgeon, A., Calvert, I. A., Beach, J., Levy L. S., Berry, H., and Harrington, J. M. 1995. Neuropsychological effects of long-term exposure to organophosphates in sheep dip. Lancet 345: 1135-1139.
54. Tafuri, J., and Roberts, J. 1987. Organophosphate poisoning. Ann. Emerg. Med. 16:193-202.
55. Taylor, P. 1996. Anticholinesterase agents. In Goodman & Gilman's The pharmacological basis of therapeutics, 9th ed., eds. J. G. Hardman, A. Goodman Gilman, and L. E. Limbred, pp. 161-176. New York: McGraw-Hill.
56. Traina, M. E., and Serpietri, L. A. 1984. Changes in the levels and forms of rat plasma cholinesterases during chronic diisopropylphosphorofluoridate i ntoxication. Biochem. Pharmacol. 33:645-653.
57. UK Pesticide Safety Directorate. 1996. Based on statements made at public industry-PSD meetings and very recent product reviews received by members of the ACRA group. London, England.
58. U.S. Environmental Protection Agency. 1988. Risk Assessment Forum Colloquium on Cholinesterase Inhibition. Washington, DC, June.
59. U.S. Environmental Protection Agency. 1991. Hazard Evaluation: Humans and Domestic Animals. Addendum 10 Neurotoxicity Series 81, 82, and 83, PB91-154617.
60. U.S. Environmental Protection Agency. 1994. Guidance Document and Process Statement for Less Than Lifetime Hazard Assessment. U.S. EPA Internal Memo, 10 January. Washington, DC.
61. U.S. Environmental Protection Agency. 1995. Proposed guidelines for neurotoxicity risk assessment. Fed. Reg. 60:52032-52056.
62. U.S. Environmental Protection Agency. 1996. Office of Pesticide Programs, Reference Dose Tracking Report. Updated quarterly by Rich J. Whiting. Washington, DC.
63. Wester R. C., and Maibach, H. I., 1993. Animal models for percutaneous absorption. In Health risk assessment: Dermal and inhalation exposure and absorption of toxicants, pp. 89-103. Boca Raton, FL: CRC Press.
64. Wills, J. H. 1972. The measurement and significance of changes in the cholinesterase activities of erythrocytes and plasma in man and animals. CRC Crit. Rev. Toxicol. 102:153-202.
65. World Health Organization. 1990. Environmental Health Criteria 104. Principles for the Toxicological Assessment of Pesticide Residues in Food. International Program on Chemical Safety. Geneva: WHO.
66. Wren, C., Carson, P. H. M., and Sanderson, J. M., 1982. Organophosphate poisoning and complete heart block. J. R. Soc. Med. 75:213.
67. Yeary, R. A., Eaton, J., Gilmore, E., North, B., and Singell, J. 1993. A multiyear study of blood cholinesterase activity in urban pesticide applicators. J. Toxicol. Environ. Health 39:11-25.
68. Yess, N. J., Gunderson, E. L., and Roy, R. R. 1993. U.S. Food and Drug Administration monitoring of pesticide residues in infant foods and adult foods eaten by infants/children. J. AOAC Int. 76(3).
69. Zendzian, R. 1991. Proposed Guidelines For Dermal Absorption Studies of Pesticides, Subdivision F Hazard Evaluation: Humans and Domestic Animals. EPA HED OPP, February. Washington, DC.